# OnCo record star-lld (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/star-lld/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "star-lld" ;
  schema:name "STAR-LLD"@en ;
  schema:alternateName "STAR-LLD-SC"@en, "STAR-LLD-OCR"@en, "continuous low-dose lenalidomide"@en ;
  schema:description "STAR-LLD is lenalidomide, an established myeloma medicine, given continuously at a low dose through a small pump under the skin or a slow-release tablet. Starton Holdings is testing it in multiple myeloma that has come back after earlier treatment."@en ;
  schema:url <https://onco.cc/drugs/star-lld/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/2049977/000121390026113388/ea0225405-18.htm>, <https://clinicaltrials.gov/study/NCT06087653> ;
  onco:status "phase-2" ;
  onco:tag "pipeline" ;
  onco:modality "Immunomodulatory drug (lenalidomide) in a continuous-delivery formulation (subcutaneous pump or oral controlled release)" ;
  onco:related <https://onco.cc/drugs/lenalidomide/> ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:companies <https://onco.cc/companies/starton-holdings/> ;
  onco:trials <https://onco.cc/trials/nct06087653/> .